C
SNDX icon

Covestor’s Syndax Pharmaceuticals SNDX Stock Holding History

Covestor’s Portfolio SNDX Stock Details SNDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$0 Hold
8
– – ﹤0.01% 2730
2025
Q4 		$0 Hold
8
– – ﹤0.01% 2699
2025
Q3 		$0 Sell
8
-29
-78% -$380 ﹤0.01% 2729
2025
Q2 		$0 Buy
37
+28
+311% +$308 ﹤0.01% 2715
2025
Q1 		$0 Buy
9
+4
+80% +$56 ﹤0.01% 2690
2024
Q4 		$0 Buy
5
+1
+25% +$17 ﹤0.01% 2695
2024
Q3 		$0 Sell
4
-1
-20% -$21 ﹤0.01% 2718
2024
Q2 		$0 Hold
5
– – ﹤0.01% 2710
2024
Q1 		$0 Hold
5
– – ﹤0.01% 2693
2023
Q4 		$0 Sell
5
-1
-17% -$15 ﹤0.01% 2672
2023
Q3 		$0 Hold
6
– – ﹤0.01% 2665
2023
Q2 		$0 Sell
6
-13
-68% -$271 ﹤0.01% 2605
2023
Q1 		$0 Buy
19
+5
+36% +$124 ﹤0.01% 2538
2022
Q4 		$0 Sell
14
-1
-7% -$23 ﹤0.01% 2561
2022
Q3 		$0 Buy
15
+3
+25% +$67 ﹤0.01% 2554
2022
Q2 		$0 Buy
+12
New +$200 ﹤0.01% 2336

Other funds holding SNDX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
EP
Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return
KCM
Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $9.98B AUM 145.42% 1-Year Est. Return

Covestor's SNDX Position: Q1 2026 in Review

Covestor held its Syndax Pharmaceuticals (SNDX) position steady in Q1 2026 at 8 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #2730.

Covestor first reported a position in SNDX in Q2 2022 and has held it in 16 quarters since. 246 funds tracked by Wall St. Rank hold SNDX as of Q1 2026.

  • Covestor held 8 shares of Syndax Pharmaceuticals worth $0 as of Q1 2026.
  • Covestor left its Syndax Pharmaceuticals share count unchanged in Q1 2026.
  • Syndax Pharmaceuticals made up ﹤0.01% of Covestor's portfolio in Q1 2026, its #2730 holding.
  • Covestor first reported a position in Syndax Pharmaceuticals in Q2 2022 and has held it in 16 quarters since.
  • 246 funds tracked by Wall St. Rank held Syndax Pharmaceuticals as of Q1 2026.

Based on Covestor's 13F filing for Q1 2026, filed 5 May 2026.